UCC patients carrying the H19 rs217727 and rs2107425 CT + TT genetic variants had a higher risk of muscle invasive tumors (OR = 1.534, 95% CI = 1.042–2.258, p = 0.030; OR = 1.586, 95% CI = 1.06–2.373, p = 0.025, respectively) than those carrying the WT gene did, but no significant differences were observed in tumor T status, lymph node status, metastasis, or histopathological grading (Table 3 and Table 4). This evidence concerns the gene H19 and neoplasm.